Gliclid 30 MR

Presentation:Modified-release tablets containing 30 mg gliclazide.  

Indications:Indicated for the management of type 2 diabetes mellitus in adults when diet and exercise alone are insufficient to achieve adequate glycemic control.  

Dosage and Administration:The usual starting dose is 30 mg once daily, taken with breakfast.Dosage may be adjusted gradually based on blood glucose levels, usually in increments of 30 mg, at intervals of at least one month, up to a maximum daily dose of 120 mg.Follow physician's instructions regarding dosage and timing. Swallow tablets whole; do not crush or chew.  

Side Effects:The most common side effect is hypoglycemia (low blood sugar), the risk of which may be increased in patients with impaired renal or hepatic function, those who miss meals, or those taking certain other medications.Symptoms of hypoglycemia can include sweating, tremor, anxiety, confusion, dizziness, and palpitations. Other potential side effects include gastrointestinal disturbances (nausea, diarrhea, constipation), skin reactions (rash, itching), and rarely, changes in blood counts or liver function.  

Precautions: Use with caution in patients with renal or hepatic impairment, elderly patients, and those with a risk of hypoglycemia. Regular blood glucose monitoring is essential. Avoid or minimize alcohol consumption. Certain medications can interact with gliclazide, affecting blood glucose control.Use during pregnancy is generally not recommended and should be avoided. Breastfeeding is contraindicated.

Storage:Store below 30°C, in a dry place, protected from light and moisture.Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.